Questionnaire-based analysis of the current status of adult bronchial asthma in Niigata Prefecture - Comparison with the asthma guidelines

Acta Medica et Biologica

Volumn 50, Issue 3, 2002, Pages 135-143

  Suzuki, Eiichi ^a   Hasegawa, Takashi ^a   Koya, Toshiyuki ^a   Mashima, Ichiro ^a   Muramatsu, Yoshiyuki ^a   Kioi, Satoru ^a   Kondoh, Ariyoshi ^a   Arakawa, Masaaki ^a   Gejyo, Fumitake ^a  

^a NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

Author keywords

Bronchial asthma; Guidelines for the management of bronchial asthma; Questionnaire; Sustained release theophylline

Indexed keywords

ACETYLSALICYLIC ACID; ANTIALLERGIC AGENT; ANTIHISTAMINIC AGENT; BECLOMETASONE; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; FLUTICASONE; LEUKOTRIENE RECEPTOR BLOCKING AGENT; PREDNISOLONE; THEOPHYLLINE;

ADULT; ARTICLE; ASTHMA; CAUSE OF DEATH; CLINICAL FEATURE; COMPARATIVE STUDY; CORTICOSTEROID THERAPY; COUGHING; DISEASE CONTROL; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PEAK EXPIRATORY FLOW; PRACTICE GUIDELINE; QUESTIONNAIRE; RISK FACTOR; SUSTAINED RELEASE PREPARATION; VENTILATOR;

EID: 0036755539     PISSN: 05677734     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Barnes PJ: New concepts in the pathogenesis of bronchial hyperresponsiveness and asthma. J Allergy Clin Immunol 83: 1013-1026, 1989.
2. Barnes PJ: Current issues for establishing inhaled corticosteroids as the antiinflammatory agents of choice in asthma. J Allergy Clin Immunol 101: S427-433, 1998.
3. Crime E, Spanevello A, Ind PW, Rossiand GA, Brusasco V: Dissociation between airway inflammation and airway hyperreponsiveness in allergic asthma. Am J Respir Crit Care Med 157: 1-3, 1998.
4. National Asthma Education and Prevention Program. "Guidelines for the Diagnosis and Management of Asthma, Expert Panel Report 2". National Institute of Health. 1997.
5. Makino S, Furusho K, Miyamoto T, Ohta K: Asthma Prevention and Management Guidelines. 1998, Japan (JGL): English version. Int Arch Allergy Immunol 121 (Suppl 1): 1-78, 2000.
6. Iamandescu IB: NSAIDs-induced asthma: Peculiarities related to background and association with other drug or non-drugs etiological agents. Allergolo Immunopathol 17: 285-290, 1989.
7. Tamaoki J, Sakai N, Nakata J, Takemura H, Nagai A, Takizawa T, Konno K: Leukotriene antagonist prevents exacerbation of asthma during reduction of high-dose inhaled corticosteroid. The Tokyo Joshi-Idai Asthma Research Group. Am J Respir Crit Care Med 155: 1235-1240, 1997.
8. Blasis L, Ernst P, Boivin JF, Suissa S: Inhaled corticosteroids and the prevention of readmission to hospital for asthma. Am J Respir Crit Care Med 158: 126-132, 1998.
9. Finnert JP, Lee C, Wilson S, Madden J, Djukanovic R, Holgate ST: Effect of theophylline on inflammatory cells and cytokines in asthmatic subjects: A placebo-controlled parallel group study. Eur Respir J 9: 1672-1677, 1996.
10. Evans DJ, Taylor DA, Zetterstrom O, Chung KF, O'Connur BJ, Barnes PJ: A comparison of low-dose inhaled budesonide plus theophylline and high-dose inhaled budesonide for moderate asthma [see comments]. New Engl J Med 337: 1412-1418, 1997.